6 . 4 Repeated Treatment 
If no adverse side effects of the treatment are observed, 
repeated injections will be considered at two-week intervals. 
Doses identical to the initial treatment regimen will be repeated 
with similar protocols and observation as described in Section 
6 . 1 . 
6.5 Postmortem Analysis 
The life expectancy of patients who enter this protocol will 
be limited, in general, less than six months. Important 
information can be obtained by analysis of tissue postmortem, 
including presence of DNA in germ line tissue, distribution of 
DNA and immune function, and potential toxicity. To maximize the 
information derived from these studies, every effort will be made 
to perform postmortem analyses. Consent for an autopsy will not 
be required for entry, but patients and their families will be 
informed of this aspect of the study and its potential 
contribution to medical knowledge. 
[7161 
Recombinant DNA Research, Volume 17 
